FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antimüllerian hormone in healthy girls: a longitudinal cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antimüllerian hormone in healthy girls : a longitudinal cohort study . / Hagen, Casper P.; Aksglaede, Lise; Sorensen, Kaspar; Mouritsen, Annette; Mieritz, Mikkel G.; Main, Katharina M.; Petersen, Jorgen Holm; Almstrup, Kristian; Meyts, Ewa Rajpert-De; Anderson, Richard A.; Juul, Anders.

In: Fertility and Sterility, Vol. 100, No. 4, 2013, p. 1089-1095.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hagen, CP, Aksglaede, L, Sorensen, K, Mouritsen, A, Mieritz, MG, Main, KM, Petersen, JH, Almstrup, K, Meyts, ER-D, Anderson, RA & Juul, A 2013, 'FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antimüllerian hormone in healthy girls: a longitudinal cohort study ', Fertility and Sterility, vol. 100, no. 4, pp. 1089-1095. https://doi.org/10.1016/j.fertnstert.2013.06.026

APA

Hagen, C. P., Aksglaede, L., Sorensen, K., Mouritsen, A., Mieritz, M. G., Main, K. M., Petersen, J. H., Almstrup, K., Meyts, E. R-D., Anderson, R. A., & Juul, A. (2013). FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antimüllerian hormone in healthy girls: a longitudinal cohort study . Fertility and Sterility, 100(4), 1089-1095. https://doi.org/10.1016/j.fertnstert.2013.06.026

Vancouver

Hagen CP, Aksglaede L, Sorensen K, Mouritsen A, Mieritz MG, Main KM et al. FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antimüllerian hormone in healthy girls: a longitudinal cohort study . Fertility and Sterility. 2013;100(4):1089-1095. https://doi.org/10.1016/j.fertnstert.2013.06.026

Author

Hagen, Casper P. ; Aksglaede, Lise ; Sorensen, Kaspar ; Mouritsen, Annette ; Mieritz, Mikkel G. ; Main, Katharina M. ; Petersen, Jorgen Holm ; Almstrup, Kristian ; Meyts, Ewa Rajpert-De ; Anderson, Richard A. ; Juul, Anders. / FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antimüllerian hormone in healthy girls : a longitudinal cohort study . In: Fertility and Sterility. 2013 ; Vol. 100, No. 4. pp. 1089-1095.

Bibtex

@article{793867521b864672901c4716b8cf41b2,
title = "FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antim{\"u}llerian hormone in healthy girls: a longitudinal cohort study ",
abstract = "Objective: To investigate whether genetic polymorphisms in the FSH pathway (FSHB- 211 G -> T and FSHR 2039 A -> G) affect serum levels of FSH, antimullerian hormone (AMH), and age at pubertal onset. FSH secretion and FSH signal transduction are enhanced in carriers of FSHB GG and FSHR AA, respectively. Furthermore, the combined genotype FSHB GG_FSHR AA is the most favorable for male gonadal function, but the effect of this genotype has never been evaluated in peripubertal females. AMH is a marker of ovarian function and is negatively correlated with FSH in prepubertal girls.Design: Secondary analyses of a prospective cohort study.Setting: General community.Patient(s): We examined 78 healthy girls twice yearly for 6 years; the median age at baseline was 9.3 years.Intervention(s): None.Main Outcome Measure(s): Hormone levels were measured by immunoassays, and DNA was isolated from blood and genotyped by restriction fragment length polymorphism of polymerase chain reaction- amplified regions.Result(s): Carriers of FSHB GG+FSHR AA had higher FSH before pubertal onset (median 2.2 vs. 1.5 IU/L) and lower AMH (13.8 vs. 19.4 pmol/L) comparedwith carriers of other genotypes. In crude analysis, girls with FSHBGG+FSHRAA entered puberty earlier, 9.7 vs. 10.6 years. However, the difference was no longer statistically significant after including interval-, right-, and left- censored data in a probit analysis.Conclusion(s): The combined effect of FSHB GG+FSHR AA may potentiate the FSH pathway, which increases serum levels of FSH and reduces AMH. Common variations in genes regulating follicle growth may affect AMH levels independently of the number of resting primordial follicles. (Fertil Steril (R) 2013;100:1089- 95. (C) 2013 by American Society for Reproductive Medicine.)",
keywords = "AMH, FSH, puberty, FSHB-211 G -> T, FSHR 2039 A -> G, FSHB, FSHR, ANTI-MULLERIAN HORMONE, FSH RECEPTOR GENE, MALE REPRODUCTIVE PARAMETERS, OVARIAN RESERVE, PROMOTER POLYMORPHISM, TURNER SYNDROME, AGE, MENOPAUSE, PUBERTY, MEN",
author = "Hagen, {Casper P.} and Lise Aksglaede and Kaspar Sorensen and Annette Mouritsen and Mieritz, {Mikkel G.} and Main, {Katharina M.} and Petersen, {Jorgen Holm} and Kristian Almstrup and Meyts, {Ewa Rajpert-De} and Anderson, {Richard A.} and Anders Juul",
year = "2013",
doi = "10.1016/j.fertnstert.2013.06.026",
language = "English",
volume = "100",
pages = "1089--1095",
journal = "Sexuality, Reproduction and Menopause",
issn = "1546-2501",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antimüllerian hormone in healthy girls

T2 - a longitudinal cohort study

AU - Hagen, Casper P.

AU - Aksglaede, Lise

AU - Sorensen, Kaspar

AU - Mouritsen, Annette

AU - Mieritz, Mikkel G.

AU - Main, Katharina M.

AU - Petersen, Jorgen Holm

AU - Almstrup, Kristian

AU - Meyts, Ewa Rajpert-De

AU - Anderson, Richard A.

AU - Juul, Anders

PY - 2013

Y1 - 2013

N2 - Objective: To investigate whether genetic polymorphisms in the FSH pathway (FSHB- 211 G -> T and FSHR 2039 A -> G) affect serum levels of FSH, antimullerian hormone (AMH), and age at pubertal onset. FSH secretion and FSH signal transduction are enhanced in carriers of FSHB GG and FSHR AA, respectively. Furthermore, the combined genotype FSHB GG_FSHR AA is the most favorable for male gonadal function, but the effect of this genotype has never been evaluated in peripubertal females. AMH is a marker of ovarian function and is negatively correlated with FSH in prepubertal girls.Design: Secondary analyses of a prospective cohort study.Setting: General community.Patient(s): We examined 78 healthy girls twice yearly for 6 years; the median age at baseline was 9.3 years.Intervention(s): None.Main Outcome Measure(s): Hormone levels were measured by immunoassays, and DNA was isolated from blood and genotyped by restriction fragment length polymorphism of polymerase chain reaction- amplified regions.Result(s): Carriers of FSHB GG+FSHR AA had higher FSH before pubertal onset (median 2.2 vs. 1.5 IU/L) and lower AMH (13.8 vs. 19.4 pmol/L) comparedwith carriers of other genotypes. In crude analysis, girls with FSHBGG+FSHRAA entered puberty earlier, 9.7 vs. 10.6 years. However, the difference was no longer statistically significant after including interval-, right-, and left- censored data in a probit analysis.Conclusion(s): The combined effect of FSHB GG+FSHR AA may potentiate the FSH pathway, which increases serum levels of FSH and reduces AMH. Common variations in genes regulating follicle growth may affect AMH levels independently of the number of resting primordial follicles. (Fertil Steril (R) 2013;100:1089- 95. (C) 2013 by American Society for Reproductive Medicine.)

AB - Objective: To investigate whether genetic polymorphisms in the FSH pathway (FSHB- 211 G -> T and FSHR 2039 A -> G) affect serum levels of FSH, antimullerian hormone (AMH), and age at pubertal onset. FSH secretion and FSH signal transduction are enhanced in carriers of FSHB GG and FSHR AA, respectively. Furthermore, the combined genotype FSHB GG_FSHR AA is the most favorable for male gonadal function, but the effect of this genotype has never been evaluated in peripubertal females. AMH is a marker of ovarian function and is negatively correlated with FSH in prepubertal girls.Design: Secondary analyses of a prospective cohort study.Setting: General community.Patient(s): We examined 78 healthy girls twice yearly for 6 years; the median age at baseline was 9.3 years.Intervention(s): None.Main Outcome Measure(s): Hormone levels were measured by immunoassays, and DNA was isolated from blood and genotyped by restriction fragment length polymorphism of polymerase chain reaction- amplified regions.Result(s): Carriers of FSHB GG+FSHR AA had higher FSH before pubertal onset (median 2.2 vs. 1.5 IU/L) and lower AMH (13.8 vs. 19.4 pmol/L) comparedwith carriers of other genotypes. In crude analysis, girls with FSHBGG+FSHRAA entered puberty earlier, 9.7 vs. 10.6 years. However, the difference was no longer statistically significant after including interval-, right-, and left- censored data in a probit analysis.Conclusion(s): The combined effect of FSHB GG+FSHR AA may potentiate the FSH pathway, which increases serum levels of FSH and reduces AMH. Common variations in genes regulating follicle growth may affect AMH levels independently of the number of resting primordial follicles. (Fertil Steril (R) 2013;100:1089- 95. (C) 2013 by American Society for Reproductive Medicine.)

KW - AMH

KW - FSH

KW - puberty

KW - FSHB-211 G -> T

KW - FSHR 2039 A -> G

KW - FSHB

KW - FSHR

KW - ANTI-MULLERIAN HORMONE

KW - FSH RECEPTOR GENE

KW - MALE REPRODUCTIVE PARAMETERS

KW - OVARIAN RESERVE

KW - PROMOTER POLYMORPHISM

KW - TURNER SYNDROME

KW - AGE

KW - MENOPAUSE

KW - PUBERTY

KW - MEN

U2 - 10.1016/j.fertnstert.2013.06.026

DO - 10.1016/j.fertnstert.2013.06.026

M3 - Journal article

VL - 100

SP - 1089

EP - 1095

JO - Sexuality, Reproduction and Menopause

JF - Sexuality, Reproduction and Menopause

SN - 1546-2501

IS - 4

ER -

ID: 119638399